Sriveda Boyalakuntla/LinkedIn
Jan 4, 2026, 21:39
Sriveda Boyalakuntla Takes The ASH25 Abstract Achievement Award
Sriveda Boyalakuntla, Volunteer at Mass General Hospital, shared on LinkedIn:
”Grateful for the opportunity to attend ASH25 and present our work on abbreviated DOAC therapy for pediatric infection-associated cerebral venous sinus thrombosis.
I’m honored to have received an Abstract Achievement Award for this work.
A huge thank you to Dr. Riten Kumar for the incredible mentorship and guidance throughout this project without whose support this experience would not be possible.
I learned so much from the conference, listening to experts in hematology, meeting inspiring professionals, and engaging with the hematology community.
I’m excited to carry these insights forward in my future endeavors.”

Stay updated with Hemostasis Today.
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications
-
Jan 6, 2026, 09:52Antoine Francis: Plasma is Not Just Another Component of Healthcare…
-
Jan 6, 2026, 09:45Hurry to Join EHC Youth Leadership Workshop 2026
-
Jan 6, 2026, 09:41Andrew Petrosoniak Makes It to N1 on EMCases Best of 2025!
-
Jan 6, 2026, 09:35Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
-
Jan 6, 2026, 09:30Wolfgang Miesbach: Excellent 4-Year Data of Etranacogene Dezaparvovec in Haemophilia B
-
Jan 6, 2026, 09:09Abdulrahman Nasiri: A New Perspective on Avatrombopag in Aplastic Anemia
